Pneumocystis jirovecii pneumonia complicated a case of SARS-CoV-2
infection and multiple sclerosis after treatment with rituximab
- Mahmoud Sadeghi Haddad Zavareh,
- Hamed Mehdinezhad,
- Rahele Mehraeen,
- Mohammad Golparvar Azizi,
- Ali Tavakoli
Mahmoud Sadeghi Haddad Zavareh
Babol University of Medical Science
Author ProfileMohammad Golparvar Azizi
Babol University of Medical Science
Author ProfileAbstract
Immunodeficient patients are less prone to develop serious complications
of COVID-19 and cytokine storm. However, they are more likely to develop
opportunistic infections that can mimic the symptoms of the SARS-CoV-2.
we presented a 27-year-old male case of SARS-CoV-2, who was complicated
with Pneumocystis jirovecii pneumonia, following treatment with
rituximab.28 Jan 2023Submitted to Clinical Case Reports 01 Feb 2023Submission Checks Completed
01 Feb 2023Assigned to Editor
10 Feb 2023Reviewer(s) Assigned
17 Feb 2023Review(s) Completed, Editorial Evaluation Pending
19 Mar 2023Editorial Decision: Revise Minor
29 Apr 20231st Revision Received
03 May 2023Submission Checks Completed
03 May 2023Assigned to Editor
03 May 2023Review(s) Completed, Editorial Evaluation Pending
18 May 2023Editorial Decision: Accept
